Basic Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. May 15, 2024; 16(5): 2074-2090
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.2074
Figure 5
Figure 5 Associations between transglutaminase 2 and JAK3 and clinicopathological characteristics in patients with KRAS mutant colon cancer. A: High expression of transglutaminase 2 predicted higher lymph node stage; B: High expression of JAK3 predicted higher lymph node stage. TGM2: Transglutaminase 2.